Concepedia

Peter R. Strack

PR

Statistics

Publications

24

Citations

3.5K

H-Index

22

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Dana-Farber Cancer Institute

Loyola University Chicago

United States Military Academy

Wilmington University

Peter R. Strack is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

1992–2015

24

Publications

24

The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro

Jeffrey Winston, Peter R. Strack, Peggy Beer‐Romero et al. · Genes & Development · 1999 · 946 citations · Full text

, , +12

<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

Jennifer O’Neil, Jonathan Grim, Peter R. Strack et al. · The Journal of Experimental Medicine · 2007 · 662 citations · Full text

, , +16

Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2.

Peter R. Strack, Michelle West Frey, Carmelo J. Rizzo et al. · Proceedings of the National Academy of Sciences · 1996 · 200 citations

, , +17

Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells

Sudhir Rao, Jennifer O’Neil, Cole D. Liberator et al. · Cancer Research · 2009 · 164 citations · Full text

, , +14

Apoptosis in T Cell Acute Lymphoblastic Leukemia Cells after Cell Cycle Arrest Induced by Pharmacological Inhibition of Notch Signaling

Huw D. Lewis, Matthew Leveridge, Peter R. Strack et al. · Chemistry & Biology · 2007 · 148 citations

, , +13

1–5 of 24